Updates are available Correction dated 2024-10-08
Click to view Correction: https://doi.org/10.1038/s41417-024-00840-1
-
Authors
Hu, Lanlin
Liu, Mingxin https://orcid.org/0000-0002-4800-1219
Tang, Bo
Li, Xurui
Xu, Huasheng
Wang, Huani
Wang, Dandan
Liu, Sijia
Xu, Chuan https://orcid.org/0000-0002-5320-2277
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (92259102)
the National Key Research and Development 431 Program of China
- License Information
-
More Information
Article History
Received: 2 April 2024
Revised: 15 August 2024
Accepted: 22 August 2024
First Online: 19 September 2024
Change Date: 30 September 2024
Change Type: Update
Change Details: The original online version of this article was revised: In this article the title was incorrectly given as ‘PRAD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3’ but should have been ‘PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3’.
Change Date: 8 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41417-024-00840-1
Competing interests
: The authors declare no competing interests.
: The tumor tissue microarray (TMA) was purchased from Outdo Biotech Co., Ltd. (China). The study using the TMA was approved by the Life Sciences Ethics Committee of Outdo Biotech Co., Ltd., under the reference number: YB M-05-02. All patients and healthy donors provided informed consent to participate.
